All Studies Meta Analysis Recent:

Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial

Villasis-Keever et al., Archives of Medical Research, doi:10.1016/j.arcmed.2022.04.003

Apr 2022

Post
Facebook

Source PDF All Meta

Vitamin D for COVID-19

8th treatment shown to reduce risk in October 2020

^*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.

Lower risk for mortality, ICU admission, hospitalization, progression, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine complementary and synergistic treatments. ^* >10% efficacy in meta analysis with ≥3 clinical studies.

4,100+ studies for 60+ treatments. c19early.org

RCT 321 healthcare workers in Mexico, showing significantly lower SARS-CoV-2 infection with vitamin D prophylaxis. 4,000IU daily for 30 days.

In comparison to Jolliffe et al., this study used a higher dose, the participants had much higher exposure to SARS-CoV-2 patients, and the study was prior to vaccination. In Jolliffe et al., 89% of participants had received a vaccine dose by the end of the study period, and the period overlapped with increasing solar UVB.

For more discussion see twitter.com.

This is the 13th of 29 COVID-19 RCTs for vitamin D, which collectively show efficacy with p=0.0000024.

This is the 76th of 120 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 248 sextillion).

1. Jolliffe et al., Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT), BMJ, doi:10.1136/bmj-2022-071230.bmj.com, doi.org.

2. twitter.com, twitter.com/KarlPfleger/status/1516918243390156800.twitter.com/KarlPfleger/status/1516918243390156800.

Important missing comments or errors? Let us know.

risk of hospitalization, 66.5% lower, RR 0.33, p = 1.00, treatment 0 of 150 (0.0%), control 1 of 152 (0.7%), NNT 152, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), ITT.

risk of case, 78.0% lower, RR 0.22, p = 0.001, treatment 7 of 150 (4.7%), control 26 of 152 (17.1%), NNT 8.0, adjusted per study, multivariable, Table 3.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Villasis-Keever et al., 18 Apr 2022, Double Blind Randomized Controlled Trial, placebo-controlled, Mexico, peer-reviewed, 16 authors, study period 15 July, 2020 - 30 December, 2020, dosage 4,000IU daily.

This Paper Vitamin D All

Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial

Miguel A Villasis-Keever, Mardia G López-Alarcón, Guadalupe Miranda-Novales, Jessie N Zurita-Cruz, Aly S Barrada-Vázquez, Joaquín González-Ibarra, Monserrat Martínez-Reyes, Concepción Grajales-Muñiz, Clara E Santacruz-Tinoco, Bernardo Martínez-Miguel, Jorge Maldonado-Hernández, Yazmín Cifuentes-González, Miguel Klünder-Klünder, Juan Garduño-Espinosa, Briseida López-Martínez, Israel Parra-Ortega

Archives of Medical Research, doi:10.1016/j.arcmed.2022.04.003

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest Mardia G López-Alarcón, is the Editor-in-Chief of Archives of Medical Research. All other authors do not have any Conflict of Interest. Arch Med Res 22-00242

References

Abbott, ARCHITECT SARS-CoV-2 IgG instructions for use

Alguwaihes, Sabico, Hasanato, Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-Arch Med Res 22-00242 15 control study in an Arab Gulf country, Aging Clin Exp Res, doi:10.1007/s40520-021-01831-0

Ali, Role of vitamin D in preventing COVID-19 infection, progression and severity, J Infect Public Health

Amer, Alotaibi, Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case-control study, J Transl Med, doi:10.1186/s12967-021-02838-x

Campi, Gennari, Merlotti, Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect Dis, doi:10.1186/s12879-021-06281-7

Cashman, Dowling, Škrabáková, D deficiency in Europe: pandemic?, Am J Clin Nutr

Castillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Arch Med Res

Chapa-Koloffon, Jean-Tron, Ávila-Hernández, Frequency of acute stress disorder in health care workers of a tertiary level pediatric hospital during the National Safe Distance Strategy for COVID-19 prevention, Bol Med Hosp Infant Mex

Chiodini, Gatti, Soranna, Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front Public Health, doi:10.3389/fpubh.2021.736665

Corman, Landt, Kaiser, Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, Euro Surveill, doi:10.2807/1560-7917.ES.2020.25.3.2000045

Crafa, Cannarella, Condorelli, Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis, E Clinical Medicine, doi:10.1016/j.eclinm.2021.100967

Ferder, Giménez, Inserra, Vitamin D supplementation as a rational pharmacological approach in the COVID-19 pandemic, Am J Physiol Lung Cell Mol Physiol, doi:10.1152/ajplung.00186.2020

Ghasemian, Shamshirian, Heydari, The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis, Int J Clin Pract, doi:10.1111/ijcp.14675

Gutiérrez, Rivera-Dommarco, Shamah-Levy, Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales

Herrick, Storandt, Afful, Vitamin D status in the United States, 2011-2014, Am J Clin Nutr

Jolliffe, Camargo, Jr, Sluyter, Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol

Kaufman, Niles, Kroll, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One, doi:10.1371/journal.pone.0239252

Liu, Sun, Wang, Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis, Int J Infect Dis

Ma, Nguyen, Yue, Associations between predicted vitamin D status, vitamin D intake, and risk of SARS-CoV-2 infection and Coronavirus Disease 2019 severity, Am J Clin Nutr, doi:10.1093/ajcn/nqab389

Malek, A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19, Rev Med Virol, doi:10.1002/rmv.2119

Murai, Fernandes, Sales, Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial, JAMA

Nogues, Ovejero, Pineda-Moncusí, Calcifediol treatment and COVID-19-related outcomes, J Clin Endocrinol Metab, doi:10.1210/clinem/dgab405

Pal, Banerjee, Bhadada, Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis, J Endocrinol Invest, doi:10.1007/s40618-021-01614-4

Petrelli, Luciani, Perego, Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2021.105883

Rastogi, Bhansali, Khare, Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study), Postgrad Med J, doi:10.1136/postgradmedj-2020-139065

Ross, Manson, Abrams, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know, J Clin Endocrinol Metab

Roth, Abrams, Aloia, Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low-and middle-income countries, Ann N Y Acad Sci

Sabico, Enani, Sheshah, Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate COVID-19: A randomized clinical trial, Nutrients, doi:10.3390/nu13072170

Van Den Ouweland, Beijers, Demacker, Van Daal, Measurement of 25-OHvitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay, J Chromatogr B Analyt Technol Life Sci

Vanherwegen, Gysemans, Mathieu, Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity, Endocrinol Metab Clin North Am

Vanherwegen, Gysemans, Mathieu, Regulation of immune function by vitamin D and its use in diseases of immunity, Endocrinol Metab Clin North Am

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0